EnvisionRheumat
EnvisionRheumat

@ERheumat

11 Tweets 36 reads Jun 02, 2022
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
Clinical Approach
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
EBUS or TBLB - the approach
cryobiopsies give larger sample
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
Use the Sarcoidosis Diagnostic Score to help in diagnosis
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
In Low-Risk patients ➡️ Just observe
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
MTX>AZR - Both take time to act
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
IFX works well in Sarcoid
In Lung, Brain and Skin
⬆️PET activity, ⬆️CRP 👉🏻 Better response
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
Not all Anti-TNFs work well
ETN ❌
Goli ❌( dose used was less)
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
3rd line 👉🏻 what are the options ?
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
Cardiac Sarcoid Mx
Neurosarcoid Mx
and Fatigue Mx
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
Manage and Suspect PAH in extensive disease
Understand risk factors for Mortality/ Morbidity

Loading suggestions...